Abzyme Therapeutics is a biopharmaceutical company focused on developing modular single domain VHH antibody fragments for immunotherapy using proprietary antibody generation platforms. The company is located in the Eastern Pennsylvania biotechnology/pharmaceutical hub 30-miles west of Philadelphia.
Unique to Abzyme is our proprietary and highly engineered eukaryotic in vitro antibody discovery/optimization platform based on yeast display self-diversifying libraries, rapid target-directed antibody affinity maturation in combination with a FACS single cell sorting approach to identify desired antibodies. Abzyme’s modular antibody discovery platform incorporates a real-time screening ability to select for key properties such as epitopic diversity, binding affinity, expressibility, solubility, developability, broad-reactivity and target-specificity.
Today, the Company has over 60 proprietary and partnered programs in development in therapeutic and diagnostic areas including infectious diseases, immuno-oncology, ophthalmology, inflammation and central nervous system disorders.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 321 Jones Boulevard,
- Phone
- 610-990-7531
- in****@****etx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- abzymetx.com
- Keywords
- Antibody devlopment, Antibody optimization, Antibody engineering, Antibody production, Therapeutic antibody, Bispecific Antibody, T-cell engaging antibody, Camelid VHH antibody, Human recombinant antibody, Single domain antibody, Immunotherapy, Human VH, CNS, Modular Antibody, Central nervous system, Blood-brain barrier, pre-targeted immunotherapy, anti-digoxigenin antibody, DIG-directed bispecific antibodies, Opnthalmology.
- HQ
- Royersford, Pennsylvania
Abzyme Therapeutics Questions
Abzyme Therapeutics's helpline number is 610-990-7531
Abzyme Therapeutics's website is abzymetx.com
Abzyme Therapeutics's LinkedIn profile is https://www.linkedin.com/company/abzymetherapeutics
Abzyme Therapeutics has
8 employees.
View email and phone details for 8
employees at Abzyme Therapeutics.
Abzyme Therapeutics's industry is
Biotechnology Research
Abzyme Therapeutics's top competitors are
Progenra, Inc.,
20n Bio,
Pulsesight Therapeutics,
Ocms Bio,
Rockland Immunochemicals, Inc.,
Psg,
Cytoex Inc.,
Exeliom Biosciences,
Interius Biotherapeutics,
Annovis Bio, Inc..
Abzyme Therapeutics's support email address is info@abzymetx.com
Abzyme Therapeutics's categories are Biotechnology Research
Abzyme Therapeutics's founding year is 2010
